Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.41 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | DBH | P09172 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30334133 | 0.88 | NPC1 (0.44) | NPC1RAB9AMAPTSMN1; SMN2CYP4F2 | |
| SCHEMBL86418 | 0.82 | KMT2A (0.55) | NPC1RAB9AMAPTSMN1; SMN2ESR1 | |
| SCHEMBL8673483 | 0.82 | L3MBTL1 (0.50) | RAB9AMAPTSMN1; SMN2GAAALDH1A1 | |
| SCHEMBL3685675 | 0.82 | KDM4E (0.50) | SMN1; SMN2CYP4F2CYP4A11KDM4EDBH | |
| SCHEMBL10053298 | 0.79 | L3MBTL1 (0.44) | NPC1RAB9AMAPTSMN1; SMN2KDM4E | |
| SCHEMBL20630223 | 0.79 | KMT2A (0.55) | RAB9AMAPTSMN1; SMN2CYP4F2CYP4A11 | |
| SCHEMBL17921593 | 0.78 | L3MBTL1 (0.46) | RAB9AMAPTKDM4EGAAALDH1A1 | |
| SCHEMBL18417676 | 0.78 | L3MBTL1 (0.46) | RAB9AMAPTKDM4EGAAALDH1A1 | |
| SCHEMBL19291179 | 0.78 | ACACB (0.41) | NPC1RAB9AMAPTSMN1; SMN2TYR | |
| SCHEMBL2387797 | 0.77 | LMNA (0.52) | NPC1RAB9AMAPTSMN1; SMN2ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129039-A1 | NOVEL PROCESS FOR THE PREPARATION OF BILASTINE AND INTERMEDIATES THEREOF | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) | 2025-04-24 | — | — | US | disclosed |
| WO-2023037184-A2 | NOVEL PROCESS FOR THE PREPARATION OF BILASTINE AND INTERMEDIATES THEREOF | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD (IN) | 2023-03-16 | — | — | WO | disclosed |
| US-8367743-B2 | Adhesion promoting photoinitiators for UV cured coatings over metal surfaces | BASF SE (DE) | 2013-02-05 | — | — | US | disclosed |
| US-20090104464-A1 | Adhesion promoting photoinitiators for UV cured coatings over metal surfaces | IGM GROUP B.V. (NL) | 2009-04-23 | — | — | US | disclosed |
| WO-2009050116-A2 | ADHESION PROMOTING PHOTOINITIATORS FOR UV CURED COATINGS OVER METAL SURFACES | BASF SE (DE) | 2009-04-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090104464-A1 | Adhesion promoting photoinitiators for UV cured coatings over metal surfaces | CDH1, PCNA, VCAM1 | NPC1 4847/4885RAB9A 2862/4885MAPT 361/4885 |
| US-20250129039-A1 | NOVEL PROCESS FOR THE PREPARATION OF BILASTINE AND INTERMEDIATES THEREOF | CYP4B1, CYP3A4, CYP7A1 | NPC1 2275/4885RAB9A 1947/4885MAPT 2844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.